Published in Cancer on June 01, 1992
Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys (2010) 2.14
Conservative treatment of invasive bladder cancer. Curr Oncol (2009) 0.95
Prescription drug use and self-prescription among resident physicians. JAMA (1998) 3.20
Predictors of laparoscopic complications after formal training in laparoscopic surgery. JAMA (1993) 2.37
Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci U S A (1987) 2.20
Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07
Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc Natl Acad Sci U S A (1990) 1.96
Susceptibility of a New World monkey to Plasmodium falciparum from man. Nature (1967) 1.85
The ets gene family. Cell Growth Differ (1992) 1.67
Isoforms of the human ets-1 protein: generation by alternative splicing and differential phosphorylation. Oncogene (1990) 1.65
Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol (1989) 1.65
Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology (2000) 1.62
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models. Proc Natl Acad Sci U S A (2001) 1.58
Correction of the NMR structure of the ETS1/DNA complex. J Biomol NMR (1997) 1.50
Mutants of Azotobacter vinelandii unable to fix nitrogen. Biochim Biophys Acta (1969) 1.44
The efficacy of treatment for malignant epidural spinal cord compression. Australas Radiol (1997) 1.43
Results of external beam radiotherapy in 448 patients with clinically localized adenocarcinoma of the prostate. Aust N Z J Surg (1994) 1.41
Characterization and localization of the products of the human homologs of the v-ets oncogene. Oncogene (1988) 1.31
Universal immuno-PCR for ultra-sensitive target protein detection. Nucleic Acids Res (1993) 1.27
A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C. Mol Cell Biol (1988) 1.23
Energy-linked nicotinamide adenine dinucleotide transhydrogenase in membrane particles from Escherchia coli. Biochim Biophys Acta (1971) 1.22
BIAcore for macromolecular interaction. Curr Opin Biotechnol (1998) 1.22
Age-related response to lidocaine-prilocaine (EMLA) emulsion and effect of music distraction on the pain of intravenous cannulation. Pediatrics (1994) 1.19
The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain intercalation. Cell (1995) 1.16
Measurement of exocytosis by amperometry in adrenal chromaffin cells: effects of clostridial neurotoxins and activation of protein kinase C on fusion pore kinetics. Biochimie (2000) 1.14
Stimulation of in vivo angiogenesis by cytokine-loaded hyaluronic acid hydrogel implants. Biomaterials (2004) 1.13
Coupling of oscillatory activity between muscles is strikingly reduced in a deafferented subject compared with normal controls. J Neurophysiol (2004) 1.13
Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization. Mol Cell Biol (2001) 1.12
Optimization of primer sequences for mouse scFv repertoire display library construction. Nucleic Acids Res (1994) 1.11
Phosphorylation of the ETS-2 protein: regulation by the T-cell antigen receptor-CD3 complex. Mol Cell Biol (1990) 1.11
Nifuratel in urinary infections. Br J Urol (1969) 1.08
Screening for dyslipidemia. J Am Board Fam Pract (1998) 1.07
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides. Cancer Res (1997) 1.07
Chemical cleavage at aspartyl residues for protein identification. Anal Chem (2001) 1.06
Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial. Clin Neuropharmacol (1998) 1.05
Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family. Oncogene (1993) 1.04
The accuracy of portable ultrasound scanning in the measurement of residual urine volume. J Urol (1994) 1.01
Split-course accelerated therapy in head and neck cancer: an analysis of toxicity. Int J Radiat Oncol Biol Phys (1995) 0.98
Laparoscopic surgical training: effectiveness and impact on urological surgical practice patterns. J Urol (1993) 0.97
An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem (1994) 0.96
Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by magnetic resonance imaging and treated with curative intent. Int J Gynecol Cancer (2008) 0.96
[Cobra bite: ophthalmic manifestations]. Harefuah (1993) 0.95
Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial. Ann Clin Psychiatry (2000) 0.93
Olanzapine compared to lithium in mania: a double-blind randomized controlled trial. Int Clin Psychopharmacol (1999) 0.93
Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder. Int J Radiat Oncol Biol Phys (1995) 0.93
The symptomatic, urodynamic and psychodynamic results of bladder re-education programs. J Urol (1983) 0.93
The aging bladder: morphology and urodynamics. World J Urol (1998) 0.93
Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis. Oncogene (1994) 0.92
Genomic alterations (LOH, MI) on chromosome 17q21-23 and prognosis of sporadic colorectal cancer. Int J Cancer (2000) 0.92
Refolding proteins by gel filtration chromatography. FEBS Lett (1994) 0.92
Ewing's sarcoma: long-term follow-up in 49 patients treated from 1967 to 1989. Int J Radiat Oncol Biol Phys (1993) 0.91
Energy-linked and energy-independent transhydrogenase activities in Escherichia coli vesicles. Biochim Biophys Acta (1975) 0.90
The role of C. albicans in denture stomatitis. Oral Surg Oral Med Oral Pathol (1979) 0.90
Relationships between lower urinary tract symptoms and bladder outlet obstruction: results from the ICS-"BPH" study. Neurourol Urodyn (1998) 0.90
The ets family of genes: molecular biology and functional implications. Curr Top Microbiol Immunol (1989) 0.89
c-Ets-1 protein is hyperphosphorylated during mitosis. Oncogene (1993) 0.89
ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl (1990) 0.89
Monoclonal antibodies specific to human ETS-2 oncoprotein: recognition of epitopes clustered on the B domain. Hybridoma (1990) 0.88
Correlates of urokinase-type plasminogen activator in colorectal cancer: positive relationship with nm23 and c-erbB-2 protein expression. Oncol Res (1998) 0.87
Control of membrane fusion dynamics during regulated exocytosis. Biochem Soc Trans (2001) 0.87
ets-1 in astrocytes: expression and transmitter-evoked phosphorylation. Mol Cell Biol (1995) 0.87
Protein markers in colorectal cancer: predictors of liver metastasis. Ann Surg (1999) 0.85
Properties and interpretation of the Woolf and Scatchard plots in analysing data from steroid receptor assays. J Steroid Biochem (1983) 0.84
Autoradiographic localization of tachykinin and calcitonin gene-related peptide receptors in adult urinary bladder. J Urol (2000) 0.84
Vascular endothelial growth factor expression is reduced in liver metastasis from colorectal cancer and correlates with urokinase-type plasminogen activator. Anticancer Res (1998) 0.84
An autoradiographic study of the early effects of 7,12-dimethylbenz(a)anthracene and progesterone on DNA synthesis in rat mammary epithelial cells and subsequent tumour development. Br J Cancer (1972) 0.84
Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect. Int J Radiat Oncol Biol Phys (1990) 0.84
Properties of a soluble nitrogenase in Azotobacter. J Bacteriol (1970) 0.84
Analysis of human immunodeficiency virus type 1 containing HERV-K protease. AIDS Res Hum Retroviruses (2000) 0.84
A field trial of ketamine anaesthesia in the horse. Equine Vet J (1984) 0.83
Escherichia coli nicotinamide adenine nucleotide transhydrogenase driven by aerobic oxidation and its enhancement by an energy transfer factor from rat-liver mitochondria. Biochem Biophys Res Commun (1970) 0.83
Radiotherapy for painful bone metastases: an overview of the overviews. Clin Oncol (R Coll Radiol) (2003) 0.83
Urinary incontinence: the Cinderella subject. Med J Aust (1996) 0.83
Urological laparoscopic practice patterns 1 year after formal training. J Urol (1994) 0.82
Selective disaggregation of the H+-translocating ATPase. Isolation of two discrete complexes of the rutamycin-insensitive ATPase differing in mitochondrial membrane-binding properties. J Biol Chem (1981) 0.82
Regulation of kiss-and-run exocytosis. Trends Cell Biol (2001) 0.82
Inhibition of the membrane-bound adenosine triphosphatase of Escherichia coli by dicyclohexylcarbodi-imide. Biochem J (1977) 0.81
A comparison of olanzapine with haloperidol in cannabis-induced psychotic disorder: a double-blind randomized controlled trial. Int Clin Psychopharmacol (1999) 0.81
Efficacy of mirtazapine add on therapy to haloperidol in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Int Clin Psychopharmacol (2001) 0.80
The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells. Biochim Biophys Acta (1996) 0.80
Relationship between radiation response and p53 status in human bladder cancer cells. Int J Radiat Biol (1997) 0.80
Iodine-125 irradiation of choroidal melanoma: clinical experience from the Prince of Wales and Sydney Eye Hospitals. Australas Radiol (1992) 0.79
Controlled trial evaluation of a General Practitioner education package on incontinence: use of a mailed questionnaire. Br J Urol (1994) 0.79
Control of NAD(P)+-transhydrogenase levels in Escherichia coli. Arch Biochem Biophys (1976) 0.79
Testicular doses in definitive radiation therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys (1995) 0.79
Chronic prostatitis--an Australian view. Br J Urol (1974) 0.79
Malakoplakia of kidney and bladder with large bowel invasion. Br J Urol (1975) 0.79
Heterogeneity of in vitro radiosensitivity in human bladder cancer cells. Radiat Oncol Investig (1999) 0.79
Pyruvate-supported nitrogen fixation by cell-free extracts of Bacillus polymyxa. Biochem J (1970) 0.79
Use of prophylactic antibiotics in urethral instrumentation. J Urol (1976) 0.79
A soluble mitochondrial ATP synthetase complex catalyzing ATP-phosphate and ATP-ADP exchange. Proc Natl Acad Sci U S A (1971) 0.78
A multi-centre, double-blind trial in general practice comparing the hypnotic efficacy and event profiles of flunitrazepam and temazepam. Pharmatherapeutica (1985) 0.78
Oral cyclophosphamide for the management of hormone-refractory prostate cancer. Br J Urol (1993) 0.78
The accuracy of a catheterized residual urine. J Urol (1989) 0.78
Effect of early inhibition of DNA synthesis by hydroxyurea on 7,12-dimethylbenz(a)anthracene mammary carcinogenesis in the rat. J Pathol (1974) 0.77
Dependence of Escherichia coli pyridine nucleotide transhydrogenase on phospholipids and its sensitivity. Biochem Biophys Res Commun (1976) 0.77
The ets genes in cells and viruses: implications for leukemias and other human diseases. Ann N Y Acad Sci (1987) 0.77